Small-Cap Momentum Watch: Upcoming Catalysts for June 15–18
6/14/20266 min read
From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week. Please note that U.S. stock markets (NYSE and Nasdaq) will be fully closed on Juneteenth National Independence Day on Friday, June 19, 2026.
--
Companies Participating at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit 2026
The H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit will be held June 15–16, 2026 in a hybrid format, featuring CNS drug development panels, company presentations, fireside chats, and networking opportunities.
CRVO, VYGR, HELP, GANX, OVID, CGTX
Companies Participating at Planet MicroCap Showcase 2026
The Planet MicroCap Showcase 2026 will take place June 16–18, 2026, at the Bellagio Hotel & Casino in Las Vegas, Nevada. The event will feature micro-cap company presentations, one-on-one investor meetings, educational panels, live webcasts, and networking opportunities.
ELUT, CTW, INDO, PLBY, LODE, DHX, CREX, ACON, FEAM, IRIX, CWD, JRSH, NXGL, COCH, INBS, MDBH, KBSX, NTRP, ATCH, AYTU, NWTG, ZDGE, IDN, EONR, DAIO, DIBS, POCI, HITI
Other Companies with Material Events This Week:
RR – Participating at HITEC 2026 in San Antonio, Texas, June 15–18, 2026, where the company will showcase its AI-powered ADAM dual-armed food and beverage service robot and DUST-E S autonomous cleaning robot. The event provides an opportunity to demonstrate how robotics can improve hospitality operations, guest experiences, and labor efficiency.
HYFT – CEO Dr. Jennifer Bath will participate in Jones AI Day on June 15, 2026, at 12:00 p.m. ET, joining a panel discussion titled “Partnering to Power the New Era of Drug Discovery.” The discussion will focus on the convergence of AI, biological data, and high-performance computing in accelerating drug discovery.
PHUN – Exhibiting at HITEC North America 2026 in San Antonio, Texas, June 15–18, 2026, where the company will showcase its AI-enabled Guest Intelligence Platform and discuss upcoming product enhancements aimed at increasing ancillary revenue opportunities for hospitality customers.
CTKB – Participating in the Singular Research Las Vegas Invitational Conference, held June 14–16, 2026, with management scheduled to present on June 15 at 11:00 a.m. PT.
ENVB – Participating in UBS 3rd Virtual CNS Day on June 15, 2026, where management will conduct one-on-one meetings with investors to discuss its neuroplastogenic pipeline, development strategy, recent achievements, and upcoming milestones.
CGEN – Presenting a trial-in-progress poster from the MAIA-Ovarian Phase 1 study at the ESMO Gynaecological Cancers Congress 2026 in Copenhagen, Denmark, June 17–19, 2026. The poster presentation is scheduled for June 18, 2026, from 12:45–1:30 p.m. CEST.
DFNS – Participating in Eurosatory 2026, one of the world's largest defense and security exhibitions, taking place in Paris, France, June 15–19, 2026. Management will meet with defense ministries, procurement officials, and industry partners to discuss autonomous systems, UAVs, AI-driven defense technologies, and acquisition opportunities.
SACH – Declared a quarterly dividend of $0.01 per share, payable on June 30, 2026, to shareholders of record as of June 15, 2026.
NUAI – Participating in the Bank of America Commodity Research Conference on June 15–16, 2026, through a virtual panel discussion.
ATAI – Participating in the H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference on June 15–16, 2026, including a company presentation and one-on-one investor meetings. Presentation scheduled for June 15 at 7:00 a.m. ET.
WLDS – Showcasing its collaboration with Meta-Bounds at Augmented World Expo (AWE) 2026 in Long Beach, California, June 16–18, 2026, demonstrating the integration of its Mudra neural interface technology with augmented reality systems.
VWAV – Participating at Eurosatory 2026 in Paris, June 15–19, 2026, where the company will publicly demonstrate its expeditionary mobility and autonomous systems ecosystem through live demonstrations, technical briefings, and partner meetings.
GTN – Announced a quarterly dividend of $0.08 per share, payable on June 30, 2026, to shareholders of record as of June 15, 2026.
FFAI – Hosting its FF EAI Robotics Education Ecosystem Strategy, Product Line & New EAI Device Launch event at its Los Angeles headquarters on June 16, 2026, providing updates on its robotics and embodied AI initiatives.
SCNI – Advancing several non-dilutive funding opportunities, including a Polish FENG grant evaluation meeting scheduled for June 16, 2026, related to its IL-17 NanoAb development program and broader therapeutic pipeline.
VTIX – Presenting at the Singular Research Las Vegas Invitational Conference on June 15, 2026, at 4:30 p.m. PT.
RZLT – Presenting at ENDO 2026 in Chicago, June 13–16, 2026. A poster titled “Outcomes in Congenital Hyperinsulinism: A Systematic Review” will be presented on June 15, 2026, from 12:00–1:30 p.m. CDT.
AGIG – Participating in the 16th Annual ROTH London Conference at the Four Seasons Hotel London, June 16–18, 2026. Management will conduct one-on-one meetings with institutional investors and discuss project development and commercialization progress.
IRD – Hosting a virtual R&D Science Forum on June 16, 2026, from 10:00 a.m.–12:00 p.m. ET, highlighting multiple inherited retinal disease gene therapy programs entering clinical testing and providing updates on ongoing clinical studies.
EMBC – Participating in the 2026 Truist Securities MedTech Conference in Boston on June 16, 2026, conducting one-on-one investor meetings.
IVVD – Participating in BTIG Infectious Disease Day 2026 on June 16, 2026, with virtual one-on-one investor meetings.
ANGX – Participating in the ROTH 16th Annual London Conference in London, June 16–18, 2026.
SAFX – CEO Chris Cooper will attend the ROTH London Conference on June 16–18, 2026, engaging with investors and industry participants focused on energy transition and sustainable aviation fuel opportunities.
MDAI – Participating in the British Burn Association Annual Meeting in Nottingham, England, June 17–19, 2026, showcasing developments in its AI-powered wound diagnostic technologies.
OPRT – Participating in the Sidoti June Virtual Investor Conference, presenting on June 17, 2026, at 4:00 p.m. ET, while also conducting investor meetings.
GAIA – Participating in the Sidoti Small Cap Investor Conference on June 17–18, 2026. The company presentation is scheduled for June 18 at 12:30 p.m. ET, with management also conducting one-on-one investor meetings.
PERF – Showcasing its latest AI and augmented reality beauty technology innovations at VivaTech 2026 in Paris, France, June 17–20, 2026.
ODYS – Participating in the 16th Annual ROTH London Conference on June 17–18, 2026, with management available for one-on-one investor meetings.
VMAR – Celebrating the grand opening of its new Nautical Ventures location in Dania Beach, Florida, on June 17, 2026, featuring product demonstrations, customer events, and on-water activities.
UIS – Participating in the Sidoti Small-Cap Virtual Investor Conference on June 17–18, 2026.
SBC – Participating in the Sidoti Small Cap Conference on June 17–18, 2026.
RBBN – Participating in the TD Cowen CEO Summit Inaugural Disruptive Technology Summit on June 17, 2026.
TMCI – Presenting at the Sidoti Small Cap Conference on June 18, 2026, at approximately 1:45 p.m. ET.
RNAZ – Hosting its first live virtual R&D Webcast on June 18, 2026, at 10:00 a.m. ET, providing updates on its Phase 2a clinical trial of TTX-MC138 and broader RNA therapeutics pipeline.
BUR – Hosting an audio webcast for retail shareholders on June 18, 2026, at 10:00 a.m. EDT, where management will discuss financial results and answer shareholder questions.
SPRO – The FDA PDUFA date for tebipenem HBr is scheduled for June 18, 2026. The NDA is supported by the successful Phase 3 PIVOT-PO study in complicated urinary tract infections.
ELDN – Presenting updated clinical data from the BESTOW Phase 2 kidney transplant studies at the American Transplant Congress (ATC) in Boston, June 20–24, 2026. A poster presentation is scheduled for June 20, 2026, from 5:45–6:45 p.m. ET.
ACHV – The FDA PDUFA date for cytisinicline for smoking cessation is June 20, 2026. Approval would be based on positive Phase 3 data and could represent a significant regulatory milestone.
LRHC – Expected closing date for its acquisition of land in St. Cloud, Florida, planned for development of a Tier III AI data center, is June 15, 2026, subject to customary closing conditions and final suitability review.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.